Hormonal contraception alters vaginal microbiota and cytokines in South African adolescents in a randomized trial

From BugSigDB
Needs review
Citation
PMID PubMed identifier for scientific articles.
DOI Digital object identifier for electronic documents.
URI
Authors
Balle C, Konstantinus IN, Jaumdally SZ, Havyarimana E, Lennard K, Esra R, Barnabas SL, Happel AU, Moodie Z, Gill K, Pidwell T, Karaoz U, Brodie E, Maseko V, Gamieldien H, Bosinger SE, Myer L, Bekker LG, Passmore JS, Jaspan HB
Journal
Nature communications
Year
2020
Young women in sub-Saharan Africa are disproportionally affected by HIV infection and unintended pregnancies. However, hormonal contraceptive (HC) use may influence HIV risk through changes in genital tract microbiota and inflammatory cytokines. To investigate this, 130 HIV negative adolescent females aged 15-19 years were enrolled into a substudy of UChoose, an open-label randomized crossover study (NCT02404038), comparing acceptability and contraceptive product preference as a proxy for HIV prevention delivery methods. Participants were randomized to injectable norethisterone enanthate (Net-En), combined oral contraceptives (COC) or etonorgesterol/ethinyl estradiol combined contraceptive vaginal ring (CCVR) for 16 weeks, then crossed over to another HC for 16 weeks. Cervicovaginal samples were collected at baseline, crossover and exit for characterization of the microbiota and measurement of cytokine levels; primary endpoints were cervical T cell activation, vaginal microbial diversity and cytokine concentrations. Adolescents randomized to COCs had lower vaginal microbial diversity and relative abundance of HIV risk-associated taxa compared to Net-En or CCVR. Cervicovaginal inflammatory cytokine concentrations were significantly higher in adolescents randomized to CCVR compared to COC and Net-En. This suggests that COC use may induce an optimal vaginal ecosystem by decreasing bacterial diversity and inflammatory taxa, while CCVR use is associated with genital inflammation.

Experiment 1


Needs review

Curated date: 2024/11/14

Curator: Tosin

Revision editor(s): Tosin

Subjects

Location of subjects
South Africa
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Vagina Vagina,vagina,Distal oviductal region,Distal portion of oviduct,Vaginae
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Vaginal microbiome measurement vaginal flora measurement,vaginal microbiota measurement,Vaginal microbiome measurement,vaginal microbiome measurement
Group 0 name Corresponds to the control (unexposed) group for case-control studies
NET-En (norethisterone enanthate ) arm
Group 1 name Corresponds to the case (exposed) group for case-control studies
COC (combined oral contraceptives) arm
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Participants (adolescents) who were randomized to combined oral contraceptives.
Group 0 sample size Number of subjects in the control (unexposed) group
28
Group 1 sample size Number of subjects in the case (exposed) group
35
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
Past 3 months

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
raw counts
Statistical test
DESeq2
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes
Confounders controlled for Confounding factors that have been accounted for by stratification or model adjustment
antibiotic exposure

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
decreased

Signature 1

Needs review

Curated date: 2024/11/14

Curator: Tosin

Revision editor(s): Tosin

Source: Table 3

Description: DESeq2 analysis of taxa differentially abundant between randomized study arms at crossover [COC (combined oral contraceptives) vs Net EN (norethisterone enanthate) arm].

Abundance in Group 1: increased abundance in COC (combined oral contraceptives) arm

NCBI Quality ControlLinks
Lactobacillus iners
Lactobacillus jensenii
Veillonella montpellierensis
Lactobacillus johnsonii
Lactobacillus gasseri
Lactobacillus taiwanensis

Revision editor(s): Tosin

Signature 2

Needs review

Curated date: 2024/11/15

Curator: Tosin

Revision editor(s): Tosin

Source: Table 3

Description: DESeq2 analysis of taxa differentially abundant between randomized study arms at crossover COC (combined oral contraceptives) vs Net EN (norethisterone enanthate ) arm].

Abundance in Group 1: decreased abundance in COC (combined oral contraceptives) arm

NCBI Quality ControlLinks
Hoylesella shahii
Lachnoanaerobaculum saburreum
Prevotella amnii
Prevotella denticola
Segatella baroniae
Segatella oulorum
Tannerella
Treponema vincentii
Weeksellaceae
Clostridium BVAB3_M_indolicusClostridium BVAB3_M_indolicus
Olsenella

Revision editor(s): Tosin

Experiment 2


Needs review

Curated date: 2024/11/14

Curator: Tosin

Revision editor(s): Tosin

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
CCVR (combined contraceptive vaginal ring) arm
Group 0 sample size Number of subjects in the control (unexposed) group
32

Lab analysis

Statistical Analysis

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged

Signature 1

Needs review

Curated date: 2024/11/15

Curator: Tosin

Revision editor(s): Tosin

Source: Table 3

Description: DESeq2 analysis of taxa differentially abundant between randomized study arms at crossover [COC (combined oral contraceptives) vs CCVR (combined contraceptive vaginal ring) arm].

Abundance in Group 1: increased abundance in COC (combined oral contraceptives) arm

NCBI Quality ControlLinks
Prevotella melaninogenica
Lactobacillus johnsonii
Lactobacillus gasseri
Lactobacillus taiwanensis

Revision editor(s): Tosin

Signature 2

Needs review

Curated date: 2024/11/15

Curator: Tosin

Revision editor(s): Tosin

Source: Table 3

Description: DESeq2 analysis of taxa differentially abundant between randomized study arms at crossover [COC (combined oral contraceptives) vs CCVR (combined contraceptive vaginal ring) arm].

Abundance in Group 1: decreased abundance in COC (combined oral contraceptives) arm

NCBI Quality ControlLinks
Enterobacteriaceae
Prevotella amnii

Revision editor(s): Tosin

Experiment 3


Needs review

Curated date: 2024/11/14

Curator: Tosin

Revision editor(s): Tosin

Differences from previous experiment shown

Subjects

Group 1 name Corresponds to the case (exposed) group for case-control studies
Net-En (norethisterone enanthate) arm
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Participants (adolescents) who were randomized to injectable norethisterone enanthate.
Group 1 sample size Number of subjects in the case (exposed) group
28

Lab analysis

Statistical Analysis

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged

Signature 1

Needs review

Curated date: 2024/11/15

Curator: Tosin

Revision editor(s): Tosin

Source: Table 3

Description: DESeq2 analysis of taxa differentially abundant between randomized study arms at crossover [Net-En (norethisterone enanthate) vs CCVR (combined contraceptive vaginal ring) arm].

Abundance in Group 1: increased abundance in Net-En (norethisterone enanthate) arm

NCBI Quality ControlLinks
Actinomyces
Bergeyella
Lachnoanaerobaculum saburreum
Prevotella nigrescens
Segatella baroniae
Segatella oulorum
Selenomonas infelix
Tannerella
Treponema
Treponema socranskii
Treponema vincentii
Weeksellaceae

Revision editor(s): Tosin

Signature 2

Needs review

Curated date: 2024/11/15

Curator: Tosin

Revision editor(s): Tosin

Source: Table 3

Description: DESeq2 analysis of taxa differentially abundant between randomized study arms at crossover [Net-En (norethisterone enanthate) vs CCVR (combined contraceptive vaginal ring) arm].

Abundance in Group 1: decreased abundance in Net-En (norethisterone enanthate) arm

NCBI Quality ControlLinks
Gardnerella
Gemelliphila asaccharolytica
Lactobacillus jensenii
Metamycoplasma hominis
Prevotella disiens

Revision editor(s): Tosin

Experiment 4


Needs review

Curated date: 2024/11/14

Curator: Tosin

Revision editor(s): Tosin

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
Net-En (norethisterone enanthate) arm
Group 1 name Corresponds to the case (exposed) group for case-control studies
COC (combined oral contraceptives) arm
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Participants (adolescents) who were randomized to combined oral contraceptives.
Group 1 sample size Number of subjects in the case (exposed) group
34

Lab analysis

Statistical Analysis

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
decreased

Signature 2

Needs review

Curated date: 2024/11/15

Curator: Tosin

Revision editor(s): Tosin

Source: Table 3

Description: DESeq2 analysis of taxa differentially abundant between randomized study arms at crossover [COC (combined oral contraceptives) vs Net EN (norethisterone enanthate) arm ].

Abundance in Group 1: increased abundance in COC (combined oral contraceptives) arm

NCBI Quality ControlLinks
Lactobacillus iners

Revision editor(s): Tosin

Signature 3

Needs review

Curated date: 2024/11/15

Curator: Tosin

Revision editor(s): Tosin

Source: Table 3

Description: DESeq2 analysis of taxa differentially abundant between randomized study arms at crossover [COC (combined oral contraceptives) vs Net EN (norethisterone enanthate) arm ].

Abundance in Group 1: decreased abundance in COC (combined oral contraceptives) arm

NCBI Quality ControlLinks
Campylobacter
Clostridium moniliforme
Clostridium perfringens
Metamycoplasma hominis
Prevotella disiens

Revision editor(s): Tosin